Home › Crohn's Disease › Nevada
Crohn's Disease clinical trials in Nevada
8 studies for Crohn's Disease are looking for participants at sites in Nevada.
Cities in Nevada
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Vector Clinical Trials, Las Vegas
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07483073A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Las Vegas Clinical Trials, North Las Vegas
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT06226883A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Vector Clinical Trials, Las Vegas
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT07483099A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Las Vegas Medical Research, Las Vegas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 2, 2026 · NCT06233461Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Vector Clinical Trials /ID# 280843, Las Vegas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07697456An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Las Vegas Clinical Trials-Site Number: 8400079, Las Vegas
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Oct 21, 2026 · NCT07184931Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Vector Clinical Trials /ID# 265561, Las Vegas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06548542A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Las Vegas
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.